Post-earnings recap
Reported
Wed, Feb 2, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Thermo Fisher Scientific's strong EPS performance indicates better-than-expected profitability, which likely contributed to the stock's 1.65% increase. The lack of revenue data and guidance may leave some investors cautious, but management's positive outlook on demand and innovation suggests potential for continued growth. Overall, the earnings report reflects resilience in a challenging environment.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $6.54 | N/A | +25.29% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in their ability to navigate current challenges. They are optimistic about future growth opportunities despite some uncertainties.
Management highlighted strong demand for their products.
They noted ongoing challenges in the supply chain but remain focused on growth.
The team emphasized their commitment to innovation and customer service.